Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP790717.RAVJSDk7uOmwh6xV1c9qFCwoynCCBrhP-yhFDIneDMzKo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP790717.RAVJSDk7uOmwh6xV1c9qFCwoynCCBrhP-yhFDIneDMzKo130_assertion type Assertion NP790717.RAVJSDk7uOmwh6xV1c9qFCwoynCCBrhP-yhFDIneDMzKo130_head.
- NP790717.RAVJSDk7uOmwh6xV1c9qFCwoynCCBrhP-yhFDIneDMzKo130_assertion description "[The cytokine LIGHT activates various anti-tumor functions through its two receptors, lymphotoxin beta receptor (LTbetaR) and herpes virus entry mediator (HVEM), and is expected to be a promising candidate for cancer therapy.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP790717.RAVJSDk7uOmwh6xV1c9qFCwoynCCBrhP-yhFDIneDMzKo130_provenance.
- NP790717.RAVJSDk7uOmwh6xV1c9qFCwoynCCBrhP-yhFDIneDMzKo130_assertion evidence source_evidence_literature NP790717.RAVJSDk7uOmwh6xV1c9qFCwoynCCBrhP-yhFDIneDMzKo130_provenance.
- NP790717.RAVJSDk7uOmwh6xV1c9qFCwoynCCBrhP-yhFDIneDMzKo130_assertion SIO_000772 20117833 NP790717.RAVJSDk7uOmwh6xV1c9qFCwoynCCBrhP-yhFDIneDMzKo130_provenance.
- NP790717.RAVJSDk7uOmwh6xV1c9qFCwoynCCBrhP-yhFDIneDMzKo130_assertion wasDerivedFrom befree-2016 NP790717.RAVJSDk7uOmwh6xV1c9qFCwoynCCBrhP-yhFDIneDMzKo130_provenance.
- NP790717.RAVJSDk7uOmwh6xV1c9qFCwoynCCBrhP-yhFDIneDMzKo130_assertion wasGeneratedBy ECO_0000203 NP790717.RAVJSDk7uOmwh6xV1c9qFCwoynCCBrhP-yhFDIneDMzKo130_provenance.